Briefing: The Best ETF Over The Past 10 Years Turned $10,000 To $65,100
Strategic angle: Discover the top-performing ETF that significantly increased investment returns over the last decade.
Editorial Staff Mar 26
Investment Funds
Latest Investment Funds stories from Money.
Briefing: Will Vanguard Growth Keep Crushing Its ETF Peers?
Strategic angle: An analysis of Vanguard Growth's performance against other ETFs.
Editorial Staff Mar 25
Briefing: DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
Strategic angle: DAFNA Capital has made adjustments to its holdings in the iShares Biotechnology ETF as part of a broader strategy in the biotech sector.
Editorial Staff Mar 21
Briefing: A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
Strategic angle: Explore the implications of a significant investment by a hedge fund in Immunovant and what it could mean for potential investors.
Editorial Staff Mar 15
Private Equity's Role in Primary Care: A Balancing Act
Recent findings suggest that while private equity is driving investment in primary care, clinician growth is tempered by a notable increase in exits.
Editorial Staff Mar 8